Ad-hoc | 2 August 2011 06:54
Fresenius Medical Care AG & Co. KGaA / Key word(s): Acquisition
02.08.2011 06:54
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Fresenius Medical Care has executed a merger agreement with Liberty
Dialysis Holdings, Inc., the holding company for Liberty Dialysis and Renal
Advantage. The investment, including assumed debt, will be approximately
$1.7bn. In addition, Fresenius Medical Care previously invested
approximately $ 300 million in Renal Advantage. The merger is subject to
clearance under the Hart-Scott-Rodino Antitrust Improvements Act and is
expected to close in early 2012. Liberty Dialysis Holdings, Inc. has annual
sales of approximately $ 1bn and operates approximately 260 dialysis
clinics. The transaction will be financed from cash flow from operations
and debt and is expected to be accretive to earnings in the first year
after closing of the transaction.
Fresenius Medical Care AG & Co. KGaA,
represented by Fresenius Medical Care Management AG,
Board of Management,
Bad Homburg v.d.H., August 2, 2011
02.08.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE
End of Announcement DGAP News-Service
---------------------------------------------------------------------------